Drug class in one race
α4 integrin drugs for Crohn's Disease
2 tracked α4 integrin drugs in the Crohn's Disease race. The class explanation lives on the α4 integrin page; the full indication pipeline across every mechanism is on the Crohn's Disease page.
2 approved / phase 4
Head-to-head evidence: natalizumab vs Tyruko (natalizumab-sztn)